EUTM file information

013052841

IBT


July 2, 2014

Trademark Summary

The trademark IBT was filed by Infant Bacterial Therapeutics AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on July 30, 2014, and received one opposition filed on October 29, 2014 by IDT Biologika GmbH on Likelihood of confusion. the opponent was represented by MAIKOWSKI & NINNEMANN PATENTANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 29, 2014

The application was filed in Swedish, and Swedish was also language of all opposition proceedings (English was selected as the second language).

The renewal of the trademark was recorded by the office on March 18, 2024.

Appointment and Replacement of representative of the trademark registration was recorded on November 10, 2016. Appointment and Replacement of representative of the trademark registration was recorded on November 12, 2018. Change of name and professional address of the trademark registration was recorded on July 14, 2022. Change of name and address of the trademark registration was recorded on April 3, 2024.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Vaccines
    2. Viral vaccines
    3. Medical preparations and items
    4. Pharmaceuticals, including biopharmaceuticals
    5. Biological preparations for medical purposes
    6. All aforementioned goods only for the treatment and prevention of human diseases and human disorders.
  • The mark was filed in class 42 with following description of goods:
    1. Research and development of vaccines and pharmaceuticals, including biopharmaceuticals
    2. Testing and counseling regarding vaccines and pharmaceutical including biopharmaceuticals
    3. Biological research and development services
    4. Scientific research for medical purposes regarding vaccines and biological pharmaceuticals for children
    5. Development of computer software for medical applications
    6. All aforementioned services only for the treatment and prevention of human diseases and human disorders.